Market research
ALBT Avalon GloboCare Corp.
NASDAQ USD Real Estate
Latest close
As of 12 Aug 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- -0.03
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Real Estate
- Industry
- Real Estate Services
- ISIN
- Not available
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- -0.03
About
About Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.
Research context
Avalon GloboCare Corp. appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Real Estate
- Industry
- Real Estate Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
0 comments
Sign in to join the ALBT discussion.
No comments yet
Start a focused discussion about ALBT.